tiprankstipranks
vTv Therapeutics (VTVT)
NASDAQ:VTVT
US Market
VTVT
vTv Therapeutics
RESEARCH TOOLSreports

vTv Therapeutics (VTVT) Stock News & Sentiment

790 Followers
Buy Rating on vTv Therapeutics Underpinned by Late-Stage T1D Catalyst, Strengthened Balance Sheet, and Diversified Partnership-Driven Upside
Premium
Ratings
Buy Rating on vTv Therapeutics Underpinned by Late-Stage T1D Catalyst, Strengthened Balance Sheet, and Diversified Partnership-Driven Upside
1M ago
VTVT
vTv Therapeutics Highlights Cadisegliatin Phase 3 and Cash Runway
Premium
Company Announcements
vTv Therapeutics Highlights Cadisegliatin Phase 3 and Cash Runway
1M ago
8K
VTVT
vTv Therapeutics Highlights Cadisegliatin Progress and Financial Strength
Premium
Company Announcements
vTv Therapeutics Highlights Cadisegliatin Progress and Financial Strength
2M ago
8K
VTVT
vTv Therapeutics Inc. (VTVT) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
vTv Therapeutics Inc. (VTVT) Q4 Earnings Cheat Sheet
2M ago
VTVT
vTv Therapeutics Expands Global HPP737 Rights with Newsoara
Premium
Company Announcements
vTv Therapeutics Expands Global HPP737 Rights with Newsoara
2M ago
8K
VTVT
vTv Therapeutics: Late-Stage Cadisegliatin Data, Differentiated Mechanism, and Partnered T2D Expansion Underpin Buy Rating and $40 Target
Premium
Ratings
vTv Therapeutics: Late-Stage Cadisegliatin Data, Differentiated Mechanism, and Partnered T2D Expansion Underpin Buy Rating and $40 Target
3M ago
VTVT
Paradigm-Shifting Potential in Type 1 Diabetes: vTv Therapeutics’ Cadisegliatin Supports Buy Rating and Significant Upside
Premium
Ratings
Paradigm-Shifting Potential in Type 1 Diabetes: vTv Therapeutics’ Cadisegliatin Supports Buy Rating and Significant Upside
3M ago
VTVT
More VTVT News >

VTVT News on the Web

Wall Street Analysts Think vTv Therapeutics (VTVT) Could Surge 31.58%: Read This Before Placing a Bet
Zacks
Bullish
Millennium Management LLC Acquires Shares in vTv Therapeutics Inc
GuruFocus News
Bullish
Analysts’ Opinions Are Mixed on These Healthcare Stocks: vTv Therapeutics (VTVT) and CSPC Pharmaceutical Group (OtherCHJTF)
TipRanks News
Bullish
Wall Street Analysts Believe vTv Therapeutics (VTVT) Could Rally 39.86%: Here's is How to Trade
Zacks
Bullish
vTv Therapeutics initiated with an Outperform at Evercore ISI
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: vTv Therapeutics (VTVT) and Oxford BioMedica (OtherOXBDF)
TipRanks News
Bullish
vTv Therapeutics price target raised to $55 from $35 at Alliance Global
TipRanks News
Bullish
Analysts Conflicted on These Healthcare Names: MoonLake Immunotherapeutics (MLTX), Sarepta Therapeutics (SRPT) and vTv Therapeutics (VTVT)
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VTVT’s Media Buzz Sentiment?
Currently, no data Available
What is VTVT’s weekly average amount of articles?
Currently, no data Available
What is VTVT’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
NBIXNeurocrine
STAAStaar Surgical
SLPSimulations Plus
OWLTOwlet
Showing the stocks with the most bullish news sentiment over the past week